+ Larger Font | - Smaller Font
Share


Sorry, Your Requested Page Was Not Found.
Greetings! We apologize for the inconvenience, but the page, Press Release Fortress Biotech Announces Pricing Of Series A Preferred Stock Offering is no longer available. Please use our search box below to find related content and browse the list of related news stories. Depending on the topic, news articles are deleted 3 - 18 months after the created date. We prefer to keep content fresh and current and not keep old news. Thanks for visiting today.
Search RobinsPost News & Noticias


Press Release Fortress Biotech Announces Pricing Of Series A Preferred Stock Offering | RobinsPost News & Noticias

Fortress Biotech Reports 2023 Financial Results and Recent Corporate Highlights


As of December 31, 2023, Fortress’ consolidated cash, cash equivalents and restricted cash totaled $83.4 million, compared to $74.7 million as of September 30, 2023, and $181.0 million as of December ... Read More

Tevogen Bio reports series A-1 preferred stock investment at $10 conversion price


Thursday said it entered into a securities purchase agreement with an existing investor. Under the agreement, the investor agreed to purchase ... Read More

Analysts Offer Insights on Healthcare Companies: Fortress Biotech (FBIO) and Phreesia (PHR)


There’s a lot to be optimistic about in the Healthcare sector as 2 analysts just weighed in on Fortress Biotech (FBIO – Research Report) ... Read More


Blow Us A Whistle


Comments (Whistles) Designed By Disqus